NovoCure NVCR

HealthcareMarket cap $3B1 connection

NovoCure makes Tumor Treating Fields - a wearable medical device that disrupts cancer cell division using alternating electric fields. FDA-approved for glioblastoma (brain cancer) and mesothelioma, it's used alongside standard therapy without the side effects of additional chemotherapy. Noninvasive electric field therapy is a wholly new treatment modality.

Explore NovoCure on the interactive map Relationship timeline Find a path to another company

Suppliers 1

Companies that sell to NovoCure

MicrosoftTechnology · $2.8TNovoCure patient data analytics on Azure

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Thermo Fisher Novartis Abbott Labs

Embed this on your site

Show NovoCure's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=NVCR" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="NovoCure on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.